SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-074767
Filing Date
2024-06-25
Accepted
2024-06-25 16:37:07
Documents
1
Period of Report
2024-06-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2418139-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2418139-3_4seq1.xml 4 5598
  Complete submission text file 0001104659-24-074767.txt   7191
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Bedrosian Camille L (Reporting) CIK: 0001326969 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38223 | Film No.: 241069416

Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Issuer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)